Tazeen Ahmad
Stock Analyst at B of A Securities
(3.19)
# 641
Out of 5,180 analysts
223
Total ratings
43.9%
Success rate
0.84%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCAX Bicara Therapeutics | Initiates: Buy | $35 | $20.50 | +70.73% | 1 | Mar 25, 2026 | |
| ACAD ACADIA Pharmaceuticals | Upgrades: Buy | $29 | $22.32 | +29.93% | 17 | Mar 25, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $139 → $149 | $88.12 | +69.09% | 11 | Mar 20, 2026 | |
| PTCT PTC Therapeutics | Maintains: Buy | $97 → $93 | $68.75 | +35.27% | 20 | Feb 20, 2026 | |
| ASND Ascendis Pharma | Maintains: Buy | $246 → $260 | $228.24 | +13.92% | 12 | Jan 30, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $529 → $462 | $328.73 | +40.54% | 7 | Jan 30, 2026 | |
| BLTE Belite Bio | Initiates: Buy | $195 | $167.25 | +16.59% | 1 | Jan 26, 2026 | |
| APLS Apellis Pharmaceuticals | Upgrades: Buy | $28 | $40.39 | -30.68% | 10 | Jan 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Upgrades: Buy | $627 → $860 | $777.25 | +10.65% | 1 | Jan 7, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $72 → $58 | $21.42 | +170.77% | 7 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $6 → $7 | $7.48 | -6.42% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $112 | $84.93 | +31.87% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $27 → $30 | $29.45 | +1.87% | 5 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $53 | $49.35 | +7.40% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $104 | $94.30 | +10.29% | 6 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $880 → $887 | $743.12 | +19.36% | 4 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $17 → $16 | $22.13 | -27.70% | 26 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $126 → $134 | $89.42 | +49.85% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $4.31 | +85.61% | 1 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $9.38 | +59.91% | 12 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $22 → $4 | $10.03 | -60.12% | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $24.87 | -67.83% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $27 | $19.68 | +37.20% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $28 | $11.33 | +147.13% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $40 | $9.87 | +305.27% | 4 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $184 → $179 | $132.56 | +35.03% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $19.77 | +11.28% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6 → $3 | $1.74 | +72.41% | 3 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.44 | +3.88% | 5 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $5.36 | +86.57% | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $2 → $6 | $1.24 | +383.87% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $8.33 | +80.07% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $2 | $3.80 | -47.37% | 2 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6 | $3.45 | +73.91% | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $75 → $15 | $28.44 | -47.26% | 3 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $390 → $60 | $319.28 | -81.21% | 2 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $16 | $1.47 | +988.44% | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $142.52 | - | 4 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $330 → $300 | $20.50 | +1,363.41% | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $19 → $9 | $2.45 | +267.35% | 2 | Oct 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $46 → $48 | $22.79 | +110.62% | 6 | Oct 10, 2018 |
Bicara Therapeutics
Mar 25, 2026
Initiates: Buy
Price Target: $35
Current: $20.50
Upside: +70.73%
ACADIA Pharmaceuticals
Mar 25, 2026
Upgrades: Buy
Price Target: $29
Current: $22.32
Upside: +29.93%
Rhythm Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $139 → $149
Current: $88.12
Upside: +69.09%
PTC Therapeutics
Feb 20, 2026
Maintains: Buy
Price Target: $97 → $93
Current: $68.75
Upside: +35.27%
Ascendis Pharma
Jan 30, 2026
Maintains: Buy
Price Target: $246 → $260
Current: $228.24
Upside: +13.92%
Alnylam Pharmaceuticals
Jan 30, 2026
Maintains: Buy
Price Target: $529 → $462
Current: $328.73
Upside: +40.54%
Belite Bio
Jan 26, 2026
Initiates: Buy
Price Target: $195
Current: $167.25
Upside: +16.59%
Apellis Pharmaceuticals
Jan 21, 2026
Upgrades: Buy
Price Target: $28
Current: $40.39
Upside: -30.68%
Regeneron Pharmaceuticals
Jan 7, 2026
Upgrades: Buy
Price Target: $627 → $860
Current: $777.25
Upside: +10.65%
Ultragenyx Pharmaceutical
Jan 2, 2026
Maintains: Buy
Price Target: $72 → $58
Current: $21.42
Upside: +170.77%
Dec 9, 2025
Maintains: Underperform
Price Target: $6 → $7
Current: $7.48
Upside: -6.42%
Dec 9, 2025
Maintains: Buy
Price Target: $71 → $112
Current: $84.93
Upside: +31.87%
Dec 4, 2025
Maintains: Neutral
Price Target: $27 → $30
Current: $29.45
Upside: +1.87%
Oct 9, 2025
Initiates: Buy
Price Target: $53
Current: $49.35
Upside: +7.40%
Sep 4, 2025
Maintains: Buy
Price Target: $90 → $104
Current: $94.30
Upside: +10.29%
Sep 2, 2025
Maintains: Buy
Price Target: $880 → $887
Current: $743.12
Upside: +19.36%
Aug 21, 2025
Maintains: Underperform
Price Target: $17 → $16
Current: $22.13
Upside: -27.70%
Aug 5, 2025
Maintains: Buy
Price Target: $126 → $134
Current: $89.42
Upside: +49.85%
Jul 11, 2025
Initiates: Buy
Price Target: $8
Current: $4.31
Upside: +85.61%
Jul 1, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $9.38
Upside: +59.91%
May 28, 2025
Downgrades: Underperform
Price Target: $22 → $4
Current: $10.03
Upside: -60.12%
May 19, 2025
Maintains: Underperform
Price Target: $10 → $8
Current: $24.87
Upside: -67.83%
May 19, 2025
Maintains: Buy
Price Target: $28 → $27
Current: $19.68
Upside: +37.20%
Mar 12, 2025
Maintains: Buy
Price Target: $54 → $28
Current: $11.33
Upside: +147.13%
Mar 10, 2025
Maintains: Buy
Price Target: $42 → $40
Current: $9.87
Upside: +305.27%
Feb 7, 2025
Maintains: Buy
Price Target: $184 → $179
Current: $132.56
Upside: +35.03%
Dec 18, 2024
Initiates: Buy
Price Target: $22
Current: $19.77
Upside: +11.28%
Dec 16, 2024
Downgrades: Underperform
Price Target: $6 → $3
Current: $1.74
Upside: +72.41%
Oct 17, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $14.44
Upside: +3.88%
Mar 28, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $5.36
Upside: +86.57%
Mar 28, 2024
Maintains: Underperform
Price Target: $2 → $6
Current: $1.24
Upside: +383.87%
Feb 9, 2024
Initiates: Buy
Price Target: $15
Current: $8.33
Upside: +80.07%
Apr 24, 2023
Downgrades: Underperform
Price Target: $7 → $2
Current: $3.80
Upside: -47.37%
Nov 21, 2022
Downgrades: Underperform
Price Target: $6
Current: $3.45
Upside: +73.91%
Nov 17, 2022
Downgrades: Underperform
Price Target: $75 → $15
Current: $28.44
Upside: -47.26%
Jun 7, 2022
Downgrades: Neutral
Price Target: $390 → $60
Current: $319.28
Upside: -81.21%
Nov 2, 2021
Initiates: Neutral
Price Target: $16
Current: $1.47
Upside: +988.44%
Apr 25, 2019
Downgrades: Underperform
Price Target: n/a
Current: $142.52
Upside: -
Nov 2, 2018
Maintains: Buy
Price Target: $330 → $300
Current: $20.50
Upside: +1,363.41%
Oct 16, 2018
Downgrades: Underperform
Price Target: $19 → $9
Current: $2.45
Upside: +267.35%
Oct 10, 2018
Maintains: Neutral
Price Target: $46 → $48
Current: $22.79
Upside: +110.62%